Concordance of tumor differentiation among brothers with prostate cancer

European Urology

Volumn 62, Issue 4, 2012, Pages 656-661

  Jansson, K Fredrik ^a   Akre, Olof ^a   Garmo, Hans ^b   Bill Axelson, Anna ^c   Adolfsson, Jan ^a   Stattin, Pär ^d   Bratt, Ola ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Regional Oncologic Center   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Familial prostate cancer; Gleason score; PCBaSe Sweden; Tumor differentiation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; STANDARDIZED INCIDENCE RATIO; TUMOR DIFFERENTIATION;

AGED; CELL DIFFERENTIATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK; SIBLINGS;

EID: 84865696634     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.02.032     Document Type: Article

References (26)

1. P. Lichtenstein, N.V. Holm, and P.K. Verkasalo Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78 85
2. W.F. Page, M.M. Braun, A.W. Partin, N. Caporaso, and P. Walsh Heredity and prostate cancer: a study of World War II veteran twins Prostate 33 1997 240 245
3. H. Gronberg, L. Damber, and J.E. Damber Studies of genetic factors in prostate cancer in a twin population J Urol 152 1994 1484 1487 discussion 1487-9
4. J. Sun, A.K. Kader, and F.C. Hsu Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer Prostate 71 2011 421 430
5. A. Brandt, J.L. Bermejo, J. Sundquist, and K. Hemminki Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members Eur Urol 58 2010 275 280
6. K. Hemminki, J. Ji, A. Forsti, J. Sundquist, and P. Lenner Concordance of survival in family members with prostate cancer J Clin Oncol 26 2008 1705 1709
7. L.S. Lindstrom, P. Hall, M. Hartman, F. Wiklund, H. Gronberg, and K. Czene Familial concordance in cancer survival: a Swedish population-based study Lancet Oncol 8 2007 1001 1006
8. L. Egevad, T. Granfors, L. Karlberg, A. Bergh, and P. Stattin Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection J Urol 168 2002 509 513
9. E. Hagel, H. Garmo, and A. Bill-Axelson PCBaSe Sweden: a register-based resource for prostate cancer research Scand J Urol Nephrol 43 2009 342 349
10. J. Adolfsson, H. Garmo, and E. Varenhorst Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 Scand J Urol Nephrol 41 2007 456 477
11. Statistics Sweden, Population and Welfare Department. Statistics Sweden, background facts, population and welfare statistics. Multigeneration register 2009. A description of contents and quality. Stockholm, Sweden: Avdelningen för befolknings- och välfärdsstatistik Statistiska centralbyrån SCB; 2010.
12. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
13. N.E. Breslow, and N.E. Day Statistical methods in cancer research. Volume II - the design and analysis of cohort studies 1987 IARC Scientific Publishing Lyon, France
14. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
15. O. Bratt, H. Garmo, and J. Adolfsson Effects of prostate-specific antigen testing on familial prostate cancer risk estimates J Natl Cancer Inst 102 2010 1336 1343
16. The R Project for Statistical Computing v.2.9.1. Vienna, Austria: R Foundation for Statistical Computing; 2009.
17. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin, and L.L. Egevad The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 2005 1228 1242
18. P.C. Albertsen, J.A. Hanley, and G.H. Barrows Prostate cancer and the Will Rogers phenomenon J Natl Cancer Inst 97 2005 1248 1253
19. S.D. Cramer, J. Sun, S.L. Zheng, J. Xu, and D.M. Peehl Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer Cancer Epidemiol Biomarkers Prev 17 2008 2451 2457
20. J. Xu, S.L. Zheng, and S.D. Isaacs Inherited genetic variant predisposes to aggressive but not indolent prostate cancer Proc Natl Acad Sci U S A 107 2010 2136 2140
21. I. Cheng, S.J. Plummer, and C. Neslund-Dudas Prostate cancer susceptibility variants confer increased risk of disease progression Cancer Epidemiol Biomarkers Prev 19 2010 2124 2132
22. R. Szulkin, E. Holmberg, and P. Stattin Prostate cancer risk variants are not associated with disease progression Prostate 72 2012 30 39
23. G. Draisma, R. Etzioni, and A. Tsodikov Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context J Natl Cancer Inst 101 2009 374 383
24. R.K. Nam, W.W. Zhang, and J. Trachtenberg Utility of incorporating genetic variants for the early detection of prostate cancer Clin Cancer Res 15 2009 1787 1793
25. C.A. Salinas, J.S. Koopmeiners, and E.M. Kwon Clinical utility of five genetic variants for predicting prostate cancer risk and mortality Prostate 69 2009 363 372
26. B.T. Helfand, D. Kan, P. Modi, and W.J. Catalona Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination Prostate 71 2011 394 402